Stock Information
ADC Therapeutics SA (ADCT)
Ticker Symbol: ADCT
Exchange: NYSE
Sector: Biotechnology
Market Cap: $391.30 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.73
Revenue (TTM): $0.51 M
Dividend Yield: N/A
ROE: -229.23%
Latest News
-
ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says
Fri, Oct 9, 2026 3:27 PM
-
ADC Therapeutics: Shares Spike On Restructuring, But Safety Fears Undermine Bull Thesis
Fri, Oct 9, 2026 10:06 AM
-
Sector Update: Healthcare Stocks Softer Late Afternoon
Thu, Oct 8, 2026 7:53 PM
-
ADC Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
Thu, Oct 8, 2026 1:00 PM
-
ADC Therapeutics Announces $86.6M Pipe Financing For 12.9M Shares At $1.42/Share And Warrants To Purchase 48.1M Shares At $1.32/Warrant; Secures Loan And Royalty Amendments
Thu, Oct 8, 2026 9:07 AM
Key Financials
Financial data not available
